Marc Pellegrini

Camperdown, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications

Common Acquisition of Broadly Neutralizing Antibodies in an HTLV-1c+ First Nations Cohort from Central Australia.

Common Acquisition of Broadly Neutralizing Antibodies in an HTLV-1c+ First Nations Cohort from Central Australia.

Journal: Viruses
Published: February 25, 2026

Immunophenotype and proviral landscape of HTLV-1c infection and pulmonary disease.

Immunophenotype and proviral landscape of HTLV-1c infection and pulmonary disease.

Journal: EBioMedicine
Published: February 23, 2026

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.

Journal: NPJ vaccines
Published: July 04, 2025

Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 29, 2025

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses.

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses.

Journal: NPJ vaccines
Published: May 26, 2025

The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir.

The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir.

Journal: PLoS pathogens
Published: May 12, 2025

A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.

A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.

Journal: Nature communications
Published: December 18, 2024

Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection.

Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection.

Journal: Nature communications
Published: November 13, 2024

IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.

IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.

Journal: Cell death and differentiation
Published: July 30, 2024

Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspring in a sex-dependent manner.

Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspring in a sex-dependent manner.

Journal: Nature communications
Published: July 26, 2024

Transient inhibition of type I interferon enhances CD8 + T cell stemness and vaccine protection.

Transient inhibition of type I interferon enhances CD8 + T cell stemness and vaccine protection.

Journal: bioRxiv : the preprint server for biology
Published: July 09, 2024

Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection.

Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection.

Journal: The Journal of experimental medicine
Published: July 04, 2024
Showing 1-12 of 100

Last Updated: 09/26/2026